Breaking News on Supplements, Health & Nutrition - North America EU edition | APAC edition

NDI draft guidance

NDI draft guidance

The Food and Drug Administration (FDA) has issued its long awaited draft guidance for new dietary ingredients (NDI), and the industry in general is not happy. NutraIngredients-USA has collected analysis and insights from the leading players in the industry, from the trade associations to leading manufacturers and the FDA itself.

NDI innovation 'pause' looks more like a freeze, UNPA chief says

According to UNPA president Loren Israelsen there has been plenty of recent innovation within the dietary supplement despite complaints to the contrary. But the NDI draft guidance could bring that...

DEA ends emergency kratom listing, begins more protracted proceeding

Under the combined pressure of industry and lawmakers, the federal Drug Enforcement Administration has backed off its emergency listing of kratom to the schedule 1 list of controlled substances.

‘Several points in the NDI draft guidance should not apply to probiotics’: Expert

The NDI draft guidance contains several points that are potentially issues for probiotics, and there appears to be a disconnect with the GRAS (generally recognized as safe) process, says a...

ChromaDex CEO says new NDI guidance could be tool to clean up marketplace

The NDI draft guidance offers a workable road map for companies willing to provide the safety information already called for by law, according to one ingredient supplier.

Panel explores issue of how best to live with NDI provisions

The consensus of a recent industry session on NDIs was this: The draft guidance is here to stay. You’d best learn to deal with it.

FDA extends NDI comment period to Dec. 12

The Food and Drug Administration has extended the comment period on the updated draft version of the New Dietary Ingredients guidance. The new deadline for comments is Dec. 12.

Guest article

New Dietary Ingredients (NDI)– A Better Solution

“Antagonistic cooperation is the principle of all markets and many marriages.” - Mason Cooley

Special edition: botanicals

NDI guidance will dampen innovation in botanicals, experts say

The NDI draft guidance as written will squelch innovation in botanical ingredients, experts have said.

NPA to develop ‘safe harbor’ list for dietary ingredients

In response to the recently re-released NDI draft guidance, the Natural Products Association (NPA) has said it is in the later stages of developing a comprehensive safe harbor list of...

More NDI training needed: A pulse on the dietary supplements industry

More than half (56%) of dietary supplement professionals said they haven’t read the Aug. 11 NDI guidance—and 6% said they haven’t read it, but told their boss that they did.

Innovation hot spot lies at overlap of 'natural,' science and sustainability, expert says

The drive toward shorter, cleaner labels and the oft-mentioned dearth of innovation in the supplement sphere are both factors of the maturation of the dietary supplement  and functional foods industries,...

From nanotechnology to master files, 5 things to think about from FDA's new NDI draft guidance

From ingredient combinations to supercritical CO2 extraction to nanotechnology, here are some things to note from the new NDI draft guidance FDA released Aug. 11.

Guest article

NDIs: When to file, what FDA wants to see, and how companies can protect themselves

Over the last few years, the FDA has zeroed in on the dietary supplement industry.  It has taken numerous actions against dietary supplements where it believes the ingredients pose health...

FDA rules vinpocetine not a legal dietary ingredient despite successful NDI filings

In what has been called an ‘unprecedented’ move, the Food and Drug Administration has initiated a proceeding to take vinpocetine off the market despite a number of successful NDI notifications...

NPA asks for NDI comment period extension

The Natural Products Association is asking FDA to add 30 days to the comment period on the updated New Dietary Ingredients draft guidance.

UNPA on the NDI draft guidance: ‘The economic cost to industry could be billions of dollars’

In addition to the areas that require clarification, the dietary supplement industry should look carefully and cautiously at the revised draft guidance for new dietary ingredient notifications, specifically at the...

Self-affirmed GRAS omitted from new NDI draft guidance

The devil is in the detail, and one detail easily missed in the new draft guidance for new dietary ingredient notifications is that self-affirmed GRAS is no longer mentioned as...


NDIs: The biggest changes may be on the industry side

The new NDI draft guidance is very similar to the previous version, and yet the howls of outrage heard in 2011 are silent. What’s changed? Well, a lot…

FDA’s new NDI draft guidance: ‘Not much that’s surprising’

The new draft guidance for new dietary ingredient notifications is “more positive than negative”, says Steve Mister, CEO of the Council for Responsible Nutrition.

GRAS route will still be popular with hard line taken in NDI draft on synthetic botanicals

The updated New Dietary Ingredients draft guidance, issued yesterday by the Food and Drug Administration, modifies the agency’s stance on the contentious issue of synthetic, nature-identical compounds. But not by...

It’s here! FDA releases new NDI draft guidance

Master Files and a grandfathered list are among the highlights in the FDA’s new Draft Guidance for New Dietary Ingredient Notifications, released this morning.

AMA warns members about rise of nootropics

A new policy by the American Medical Association on nootropics once again highlights the blurred edges of what can legitimately be called a ‘dietary supplement.’

FDA’s new dietary supplement office should focus on tainted products, GMPs & NDIs, industry leaders say

With the recent elevation of dietary supplement oversight from a division to its own office at FDA’s Center for Food Safety and Applied Nutrition, the agency should renew its focus...

BGG to use new Mexico City office as springboard for Latin America expansion

Chinese supplier BGG is taking a big step to expand the global footprint of its ingredients with recent establishment of an office in Mexico City to go along with a...

News in brief

AlgaeLife successful with NDI petition with FDA for astaxanthin ingredient

BGG subsidiary AlgaeLife Sciences, Inc. has successfully petitioned the US FDA with a New Dietary Ingredients notification (NDI) for its flagship product AstaZine Natural Astaxanthin. 

Live Supplier Webinars

The NutraIngredients-USA Pre-&Probiotics forum
William Reed Business Media
Healthy Living for Consumers: Trends, Challenges and Innovative Dose Forms
Catalent Pharma Solutions

On demand Supplier Webinars

The NutraIngredients-USA Botanicals Forum
William Reed Business Media
The NutraIngredients-USA Sports Nutrition Forum
William Reed Business Media
The NutraIngredients-USA Anti-Aging Forum
William Reed Business Media
All supplier webinars